搜索临床试验以:托卡 511
总计2173个结果
-
Naga P. ChalasaniNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Intercept Pharmaceuticals终止
-
Cedars-Sinai Medical CenterHarvard Medical School (HMS and HSDM); National Institute of Diabetes and Digestive and Kidney... 和其他合作者撤销
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development完全的
-
Samueli Institute for Information BiologyU.S. Army Medical Research and Development Command; Defense Centers of Excellence for Psychological...完全的
-
Chong Kun Dang Pharmaceutical完全的
-
The 108 Military Central HospitalCharles Drew University of Medicine and Science完全的
-
Massachusetts Eye and Ear InfirmaryBoston Children's Hospital; University of Washington招聘中
-
Arcutis Biotherapeutics, Inc.完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital完全的
-
Bellicum Pharmaceuticals主动,不招人
-
Celgene终止
-
Arcutis Biotherapeutics, Inc.完全的
-
Chong Kun Dang Pharmaceutical完全的
-
Qlaris Bio, Inc.招聘中
-
Krankenhaus Barmherzige Schwestern LinzMedical University of Vienna完全的
-
BioNTech Research & Development, Inc.SciQuus Oncology终止
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Bellicum Pharmaceuticals撤销复发性急性髓性白血病 | 复发性慢性粒单核细胞白血病 | 复发性骨髓增生异常综合征 | 复发性急性淋巴细胞白血病 | 复发性慢性粒细胞白血病,BCR-ABL1 阳性 | 骨髓增殖性肿瘤 | 骨髓增生异常/骨髓增生性肿瘤 | 骨髓增生异常/骨髓增生性肿瘤,无法分类 | 急性双系白血病 | 复发性急性双表型白血病 | 复发性慢性淋巴细胞白血病 | 复发性母细胞性浆细胞样树突状细胞肿瘤美国